
Postdoc Fellow in Pharmacoepidemiology @HkuPharm | Pharmacist | #cardiovascular #mentalhealth #datascience #programming
Hong Kong
Joined August 2022
- Tweets78
- Following101
- Followers111
- Likes115
Vincent Yan retweeted
Our latest study has been published in
@AnnalsofIM. The DOAC group had a higher 1-year risk of stroke than warfarin in Asian AF-MS patients. We also found that rivaroxaban increased the risk of stroke, while non-rivaroxaban DOACs did not.
Full paper: acpjournals.org/doi/10.7326/…
Vincent Yan retweeted
I am glad to share our published paper in Value in Health Regional Issues on patient preferences for lipid-lowering agents in hypercholesterolemia using a DCE.
These insights support more patient-centered lipid-lowering strategies and improve adherence. lnkd.in/gdVzNh8P
Vincent Yan retweeted
Our research letter on @JInternMed shows that #GLP1RA therapy exhibits no significant difference in #depression risk across diverse populations, though routine clinical monitoring of patients' #mental health is recommended to ensure safe prescribing.
onlinelibrary.wiley.com/doi/…
Vincent Yan retweeted
In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis #MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
onlinelibrary.wiley.com/doi/…
Vincent Yan retweeted
Our @AnnalsofIM paper found that #statins initiation associates with reductions of all-cause #mortality & #CVD in #T2DM adults, including low-risk groups. Results suggest statins initiation in T2DM adults even when short-term predicted CVD #risk is low.
acpjournals.org/doi/10.7326/…
Vincent Yan retweeted
Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
thelancet.com/journals/lanwp…
Vincent Yan retweeted
Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU
thelancet.com/journals/lanps…
Vincent Yan retweeted
Our modified self-controlled case series (dx.doi.org/10.1002/pds.70219) did not identify an increased #ischemic_stroke risk with #PPI_monotherapy. However, co-prescription with #antithrombotics was associated with a higher risk. Careful monitoring is needed for them.
@ChuiCeline
Vincent Yan retweeted
Our @JACCJournals paper found that #statin use for primary #prevention was associated in all-cause #mortality and major #CVD reductions with a very low risk of adverse effects among #T1DM adults, guiding personalized statin #treatment decisions in T1DM.
sciencedirect.com/science/ar…
Vincent Yan retweeted
"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read ascpt.onlinelibrary.wiley.co…
Vincent Yan retweeted
The #validated #Cantonese-Chinese #translation of the Pharmacy Services #Questionnaire #PSQ is a reliable #instrument to assess services #satisfaction by community pharmacies. See full article published in @editorjoppp
tandfonline.com/doi/full/10.…
Vincent Yan retweeted
Our multinational network cohort study shows that extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium- and long-term. journals.sagepub.com/doi/10.…
Vincent Yan retweeted
Thanks a lot for the professional editing from the Lancet Group. Our podcast about biologics access and recent policy development in Asia Pacific is now on air from the Lancet Rheumatology and the Lancet Regional Health Western Pacific. buzzsprout.com/1907323/episo…
Vincent Yan retweeted
Read the full paper here: sciencedirect.com/science/ar…
Vincent Yan retweeted
Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with @SpringerNature in @CommsMedicine
Read here: rdcu.be/eocfU
@Ian_HKU @ChuiCeline @KennethKCMan @Knappem @GloW_hk
Vincent Yan retweeted
Our study, the largest conducted to date examining various classes of antihypertensive drugs and dementia risk. We found a lower risk of all-cause dementia with ARBs compared to ACE inhibitors. Hong Kong, UK, Sweden, and Australia data included.
doi.org/10.1093/ageing/afaf1…
Vincent Yan retweeted
Country Income, Gini Index, Disease Burden and Universal Health Coverage, which one you would expect as the driving factor for the access of WHO essential cancer medicine? Read our fresh online paper on Lancet Oncology.sciencedirect.com/science/ar… @hkumed @HkuPharm @CSMPR_HKUPharm
I am honored to be the Founding President of ISPE HK Student Chapter, a student-led initiative to promote knowledge exchange and networking in HK #PharmacoEpi community
Many thanks to our advisors @ChuiCeline @Esther_CSMPRHKU and team Eunice, Jack, Tina for their support
🚀 We're thrilled to announce the official launch of the International Society for Pharmacoepidemiology Hong Kong Student Chapter (ISPE HKSC)!
Join our community! Follow us for networking, mentorship, and hands-on workshops and more! 🙌🏻
forms.gle/guxrUtmYEW9DNGqw6
Vincent Yan retweeted
In this study Vincent Ka Chun Yan and colleagues investigate the prescribing trends of indapamide and the long term comparative effectiveness of modified release versus immediate release indapamide.
Read the full research article here: bit.ly/4bnRjc6
Vincent Yan retweeted
A great collaboration between UCL, University of Dundee and HKU. Congratulations to @VincentKCYan @ChengshengJ Tom MacDonald, Isla Mackenzie, Rob Flynn, Bryan Williams, Yang Chen, Esther Chan, Jacob George & Li Wei for the publication of indapamide study bmjmedicine.bmj.com/content/…















